| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Samsara Biocapital, L.P. is a 10% Owner at LENZ Therapeutics, Inc.. Recent SEC Form 4 filings include 16 buys and 0 sells.
Estimated insider holdings value: $85.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2022 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Buy | 424,464 | $4.08 | $1,731,068.48 | +2.6% | -21.3% | -38.9% | |
| Jan 24, 2022 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Buy | 123,000 | $8.94 | $1,099,100.00 | +0.8% | -53.3% | -79.0% | |
| Jan 20, 2022 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Buy | 97,670 | $9.10 | $888,677.20 | +0.6% | -55.3% | -78.4% | |
| Dec 15, 2021 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Buy | 22,329 | $10.19 | $227,532.51 | +0.3% | -28.7% | -72.5% | |
| Nov 22, 2021 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Buy | 201,685 | $10.15 | $2,047,102.75 | +2.7% | -5.0% | -60.9% | |
| Oct 15, 2021 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Buy | 50,800 | $13.14 | $667,665.00 | +0.2% | -21.6% | -76.1% | |
| Oct 8, 2021 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Buy | 145,496 | $13.53 | $1,968,972.99 | +0.7% | -16.9% | -76.0% | |
| Jun 29, 2021 | LENZ Lenz Therapeutics, Inc. | 10% Owner | Buy | 500,000 | $17.00 | $8,500,000.00 | +7.2% | -39.1% | -89.9% |